findmyKOL
Clinical trialNCT07358546RecruitingPhase 1Interventional

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

SponsorGlaxoSmithKlineEnrollment32Non-alcoholic Fatty Liver Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is designed to study the pharmacokinetic (PK) and safety profiles of a single dose of efimosfermin alfa in participants with varying degrees of Hepatic Impairment (HI) (assessed by Child-Pugh score) due to steatotic liver disease, with and without significant alcohol consumption.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Gsk Investigational Site

    Rialto, California, United States

    Zeid Kayali
    Recruiting
  • Gsk Investigational Site

    Tampa, Florida, United States

    Jesus Navarro
    Recruiting
  • Gsk Investigational Site

    San Antonio, Texas, United States

    Eric Lawitz →
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Efimosfermin alfa
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Mar 2026
Primary completion
13 Oct 2027
Completion
13 Oct 2027
Last update posted
9 Jun 2026
Registered enrollment
32
Registry id
NCT07358546
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.